Shanghai OPM Biosciences Co., Ltd. (SHSE: 688293)
Health Care · Biotechnology · CN
CN¥61.75
-6.96% today · +6.0% 1Y
Shanghai OPM Biosciences Co., Ltd. (SHSE: 688293) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.28B.
Over the last twelve months the share price has gained 6.0%, trading between 34.13 and 71.88.
Tweenvest scores Shanghai OPM Biosciences Co., Ltd. across four factors: quality 66/100, value 11/100, growth 91/100, dividend 33/100. Its strongest factor is growth.
688293 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.28B
- Revenue (TTM)
- $65.73M
- P/E
- 209.31
- EPS
- 0.30
- Dividend yield
- 0.70%
- Beta (5Y)
- 0.65
- 52-week high
- CN¥71.88
- 52-week low
- CN¥34.13
- Avg volume (3M)
- —
- Shares outstanding
- 139.27M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $467.44B | $264.52 | -0.17% |
| Amgen Inc.NasdaqGS: AMGN | $239.95B | $443.84 | +1.03% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.95B | $146.74 | +0.42% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.79B | $547.59 | -0.08% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $82.73B | $828.50 | -0.66% |
| argenx SEENXTBR: ARGX | $63.06B | €874.20 | +1.16% |
| CSL LimitedASX: CSL | $57.94B | AU$169.11 | +0.48% |
| Moderna, Inc.NasdaqGS: MRNA | $55.45B | $141.77 | +2.07% |
Figures last refreshed Aug 18, 2026.